Transcriptional activity is dependent not only on the binding of transcription factors to cis-acting elements, but also on the ability of those factors to recruit a complex hierarchy of proteins to stabilize the basal transcriptional machinery. Oncogenic Ras signaling to the rat prolactin (rPRL) promoter is dependent on the interaction of the proto-oncoprotein c-Ets-1, a member of the Ets family of transcription factors, with the pituitary-specific transcription factor, Pit-1, at a composite Ets/Pit-1 DNA binding element (RRE) in the rPRL promoter. This signaling cascade utilizes a tripartite code comprised of Pit-1 and Ets-1 binding to the unique RRE element, the physical interaction of the Ets-1 Rill TAD with the Pit-1 homeodomain, and Ras-stimulated MAPkinase phosphorylation of threonine 82 in Ets-1. Together this code creates a structural platform for the binding of a transcriptional regulatory complex through which Ras can mediate activation of the rPRL promoter. Recent studies suggest that the phosphorylation of Pit-1 can modulate both Ras signaling and Ets-1/Pit-1 binding. Thus, I hypothesize that the Pit-1/Ets-1 complex binding to the RRE mediates the oncogenic Ras response of the rPRL promoter by recruiting specific transcription regulatory proteins to a unique interaction face. The goals of this proposal are to determine the mechanism by which phosphorylation of Pit-1 inhibits Ras-activation of the rPRL promoter, and to use liquid chromatography/mass spectrometry methods to identify the protein components that are recruited by Ras signaling to the Ets-1/Pit-1 complex. Therefore, these studies are important to my career development as they will allow me to gain expertise in the cutting edge field of proteomics and protein structure-function relationships, which I can then utilize to establish my career as an independent investigator.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Scientist Development Award - Research & Training (K01)
Project #
5K01DK002946-05
Application #
6850682
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Hyde, James F
Project Start
2004-03-01
Project End
2006-12-31
Budget Start
2005-01-01
Budget End
2006-12-31
Support Year
5
Fiscal Year
2005
Total Cost
$109,082
Indirect Cost
Name
University of Colorado Denver
Department
Other Health Professions
Type
Schools of Pharmacy
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Jean, Annie; Gutierrez-Hartmann, Arthur; Duval, Dawn L (2010) A Pit-1 threonine 220 phosphomimic reduces binding to monomeric DNA sites to inhibit Ras and estrogen stimulation of the prolactin gene promoter. Mol Endocrinol 24:91-103
Jonsen, Matthew D; Duval, Dawn L; Gutierrez-Hartmann, Arthur (2009) The 26-amino acid ss-motif of the Pit-1ss transcription factor is a dominant and independent repressor domain. Mol Endocrinol 23:1371-84
Gutierrez-Hartmann, Arthur; Duval, Dawn L; Bradford, Andrew P (2007) ETS transcription factors in endocrine systems. Trends Endocrinol Metab 18:150-8
Duval, Dawn L; Jonsen, Matthew D; Diamond, Scott E et al. (2007) Differential utilization of transcription activation subdomains by distinct coactivators regulates Pit-1 basal and Ras responsiveness. Mol Endocrinol 21:172-85